SCHEMBL9214980

SCHEMBL9214980

O=C1Cc2c(-c3ccc(Cl)cc3)ccnc2N1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 3/20 0.47
CDK5R1 Q15078 3/20 0.47
CCNB2 O95067 2/20 0.47
CDK1 P06493 2/20 0.47
CCNB1 P14635 2/20 0.47
CCNB3 Q8WWL7 2/20 0.47
TDP2 O95551 1/20 0.44
ADORA1 P30542 1/20 0.40
LRRK2 Q5S007 1/20 0.40
MAPT P10636 3/20 0.39
THRB P10828 1/20 0.39
CMA1 P23946 1/20 0.39
AHR P35869 1/20 0.39
ENPP1 P22413 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PDE3B Q13370 2/20 0.37
PDE3A Q14432 2/20 0.37
GSK3B P49841 3/20 0.36
GSK3A P49840 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5893931 0.84 CDK5 (0.50) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL1699143 0.80 MEN1 (0.44) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL580431 0.76 CDK5 (0.47) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL25983870 0.76 JAK2 (0.43) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL7657140 0.76 LRRK2 (0.42) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL31061181 0.76 AURKA (0.44) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL730358 0.74 PIK3CA (0.53) PDE3BPDE3A
SCHEMBL6324288 0.73 CCNB2 (0.49) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL19357884 0.71 LRRK2 (0.41) CCNB2CDK1CCNB1CCNB3ADORA1
Bromide SCHEMBL29710350 0.70 LRRK2 (0.40) CCNB2CDK1CCNB1CCNB3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0660833-A1 3,3'-DISUBSTITUTED-1,3-DIHYDRO-2H-PYRROLO 2,3-b]HETEROCYCLIC-2-ONE USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS OF MAN THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-07-05 EP disclosed